Pliant Therapeutics, Inc. (PLRX) Reports In-Line Q1 EPS

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.67), in-line with the analyst estimate of ($0.67). Revenue for the quarter came in at $1.33 million versus the consensus estimate of $1.4 million.

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c